ANIXA BIOSCIENCES INC's ticker is ANIX and the CUSIP is 03528H109. A total of 46 filers reported holding ANIXA BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $39,239 | -29.2% | 17,755 | 0.0% | 0.00% | – |
| Q1 2024 | $55,396 | -74.3% | 17,755 | -68.1% | 0.00% | – |
| Q4 2023 | $215,918 | +16.7% | 55,649 | -1.6% | 0.00% | – |
| Q3 2023 | $185,023 | +2.4% | 56,582 | +0.2% | 0.00% | – |
| Q2 2023 | $180,742 | -26.2% | 56,482 | -0.8% | 0.00% | – |
| Q1 2023 | $244,881 | +0.7% | 56,949 | -0.5% | 0.00% | – |
| Q4 2022 | $243,172 | -18.7% | 57,217 | -6.0% | 0.00% | – |
| Q3 2022 | $299,000 | +49.5% | 60,846 | -7.1% | 0.00% | – |
| Q2 2022 | $200,000 | +11.1% | 65,518 | -0.1% | 0.00% | – |
| Q1 2022 | $180,000 | +6.5% | 65,568 | +15.2% | 0.00% | – |
| Q4 2021 | $169,000 | -31.3% | 56,902 | +10.4% | 0.00% | – |
| Q3 2021 | $246,000 | +17.1% | 51,550 | -4.6% | 0.00% | – |
| Q2 2021 | $210,000 | +6.1% | 54,056 | +27.7% | 0.00% | – |
| Q1 2021 | $198,000 | +1137.5% | 42,330 | +321.6% | 0.00% | – |
| Q1 2020 | $16,000 | -51.5% | 10,040 | 0.0% | 0.00% | – |
| Q4 2019 | $33,000 | -17.5% | 10,040 | 0.0% | 0.00% | – |
| Q3 2019 | $40,000 | +11.1% | 10,040 | 0.0% | 0.00% | – |
| Q2 2019 | $36,000 | – | 10,040 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SEGALL BRYANT & HAMILL, LLC | 17,400 | $27,000 | 0.00% |
| NORTHERN TRUST CORP | 53,722 | $86,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 341,645 | $543,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 102,487 | $162,000 | 0.00% |
| BlackRock Inc. | 79,981 | $128,000 | 0.00% |
| Bank of New York Mellon Corp | 39,381 | $63,000 | 0.00% |
| JPMORGAN CHASE & CO | 1,546 | $2,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 5,162 | $8,000 | 0.00% |
| MORGAN STANLEY | 14,412 | $23,000 | 0.00% |